FIELD: biotechnology, medicine. SUBSTANCE: invention relates to curative-prophylaxis preparation based on human leukocyte interferon. Preparation "Locferon" has interferon synthesized by donor blood leukocytes induced by virus strain-inducer of virus parainfluenza-1 Sendai GKV N 2339. Preparation is concentrated and purified by ultrafiltration. Preparation has 8000 IU antiviral activity in one ampoule - interferon, cellular mediators of molecular mass 10-100 kDa, ovalbumin - less 1 ng/ml, sodium chloride and stabilizing agent. "Locferon" inhibits multiplication of broad spectrum viruses - herpes viruses, adenoviruses, enteroviruses and others. Preparation blocks intracellular replication of viral particles and activates protective cellular response reactions. EFFECT: enhanced effectiveness of preparation. 3 cl
Title | Year | Author | Number |
---|---|---|---|
ANTIBACTERIAL PREPARATION | 2003 |
|
RU2272646C2 |
PREPARATION POSSESSING ANTIVIRAL AND IMMUNOCORRECTING EFFECT | 2004 |
|
RU2262946C1 |
ANTIVIRAL AGENT - EYE DROPS "OFTALMOFERON" | 1999 |
|
RU2140286C1 |
ANTIVIRAL AND ANTIBACTERIAL AGENT "INTERLISIN" | 2001 |
|
RU2188665C1 |
GEL-LIKE EYE DROPS FOR TREATMENT OF INFLAMMATORY ALLERGIC, BACTERIAL, VIRAL, TRAUMATIC AND DYSTROPHIC EYE DISEASES | 2014 |
|
RU2561046C1 |
ANTIVIRAL AGENT - EYE DROPS | 2012 |
|
RU2473363C1 |
DRUG HERPFERON-2 POSSESSING ANTIVIRAL, ANTI-INFLAMMATORY, IMMUNOMODULATORY AND ANALGESIC ACTION FOR LOCAL AND EXTERNAL APPLICATION | 2012 |
|
RU2488405C1 |
RECOMBINANT INTERFERON-BASE ANTIVIRAL AGENT AS OINTMENT, SUPPOSITORY, CREAM, LINIMENT | 1999 |
|
RU2150291C1 |
PREPARATION FOR TREATMENT AND PROPHYLAXIS OF VIRAL DISEASES | 2000 |
|
RU2185822C2 |
MEDICINAL GEL | 2000 |
|
RU2184564C2 |
Authors
Dates
1998-04-20—Published
1997-06-24—Filed